• Development of Clinical Criteria for Functional Assessment to Predict Primary Nonfunction of High-Risk Livers Using Normothermic Machine Perfusion. 

  Mergental, H; Stephenson, BTF; Laing, RW; Kirkham, AJ; Neil, DAH; Wallace, LL; Boteon, YL; Widmer, J; Bhogal, RH; Perera, MTPR; Smith, A; Reynolds, GM; Yap, C; Hübscher, SG; Mirza, DF; Afford, SC (2018-10)

  Increased use of high-risk allografts is critical to meet the demand for liver transplantation. We aimed to identify criteria predicting viability of organs, currently declined for clinical transplantation, using functional ...
• Assessment of molecular relapse detection in early-stage breast cancer 

  Garcia-Murillas, I; Chopra, N; Comino-Mendez, I; Beany, M; Tovey, H; Cutts, R; Swift, C; Kriplani, D; Afentakis, M; Hrebien, S; Walsh-Crestani, G; Barry, P; Johnston, S; Ring, A; Bliss, J; Russell, S; Evans, A; Skene, A; Wheatley, D; Dowsett, M; Smith, I; Turner, N
• Design and synthesis of dual kinase-bromodomain inhibitors targeting ALK and BRD4 

  Watts, E (2019-12-31)

  Neuroblastoma is a paediatric cancer of neural crest origin and is the most common extracranial tumour in childhood. In high-risk patients with poor clinical outcome, mutations within the kinase domain of anaplastic lymphoma ...
• Removing rician bias in diffusional kurtosis of the prostate using real-data reconstruction. 

  Goodburn, RJ; Barrett, T; Patterson, I; Gallagher, FA; Lawrence, EM; Gnanapragasam, VJ; Kastner, C; Priest, AN (2019-11-18)

  PURPOSE: To compare prostate diffusional kurtosis imaging (DKI) metrics generated using phase-corrected real data with those generated using magnitude data with and without noise compensation (NC). METHODS: Diffusion-weighted ...
• Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. 

  Bisogno, G; De Salvo, GL; Bergeron, C; Gallego Melcón, S; Merks, JH; Kelsey, A; Martelli, H; Minard-Colin, V; Orbach, D; Glosli, H; Chisholm, J; Casanova, M; Zanetti, I; Devalck, C; Ben-Arush, M; Mudry, P; Ferman, S; Jenney, M; Ferrari, A; European paediatric Soft tissue sarcoma Study Group (2019-11)

  BACKGROUND: For more than three decades, standard treatment for rhabdomyosarcoma in Europe has included 6 months of chemotherapy. The European paediatric Soft tissue sarcoma Study Group (EpSSG) aimed to investigate whether ...

View more